STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Period	PE Ratio
2015-12-31	-124.06
2016-12-31	N/A
2017-12-31	-421.80
2018-12-31	175.75
2019-12-31	65.91
2020-12-31	162.23
2021-12-31	40.56
2022-12-31	26.04
2023-12-31	47.93
2024-12-31	-51.44

	A	B	C	D
1	Symbol	Price	Change	Volume
2	STAA	$21.09	+0.00%	0.90M
3
4
5

STAAR Surgical Company (STAA) PE Ratio

PE Ratio Data

Get STAAR Surgical Company Data in Excel

More STAA Financial Data